Author pages are created from data sourced from our academic publisher partnerships and public sources.
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].
Authors/Task Force Members: Silvia G. Priori* (Chairperson) (Italy), Carina Blomström-Lundqvist* (Co-chairperson) (Sweden), Andrea Mazzanti† (Italy), Nico Blom (The Netherlands), Martin Borggrefe… Expand
Eplerenone in patients with systolic heart failure and mild symptoms.
BACKGROUND Mineralocorticoid antagonists improve survival among patients with chronic, severe systolic heart failure and heart failure after myocardial infarction. We evaluated the effects of… Expand
Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis
- J. V. van Melle, P. de Jonge, +5 authors M. van den Berg
- Psychosomatic medicine
- 1 November 2004
Objective: To assess the association of depression following myocardial infarction (MI) and cardiovascular prognosis. Methods: The authors performed a meta-analysis of references derived from… Expand
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
- S. Priori, C. Blomström-Lundqvist, +15 authors D. V. van Veldhuisen
- Revista espanola de cardiologia
- 1 February 2016
ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AGNES : Arrhythmia Genetics in the Netherlands AHA : American Heart… Expand
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
AIMS Large randomized trials have shown that beta-blockers reduce mortality and hospital admissions in patients with heart failure. The effects of beta-blockers in elderly patients with a broad range… Expand
Rosuvastatin in older patients with systolic heart failure.
- J. Kjekshus, E. Apetrei, +25 authors J. Wikstrand
- The New England journal of medicine
- 29 November 2007
BACKGROUND Patients with systolic heart failure have generally been excluded from statin trials. Acute coronary events are uncommon in this population, and statins have theoretical risks in these… Expand
Outcome of pregnancy in women with congenital heart disease: a literature review.
- W. Drenthen, P. Pieper, +9 authors D. V. van Veldhuisen
- Journal of the American College of Cardiology
- 19 June 2007
A search of peer-reviewed literature was conducted to identify reports that provide data on complications associated with pregnancy in women with structural congenital heart disease (CHD). This… Expand
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Abstract Aims. Galectin-3 is an emerging biomarker which has been studied in relatively small heart failure (HF) cohorts with predominantly systolic HF. We studied the prognostic value of base-line… Expand
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
- T. Suter, M. Procter, +17 authors M. Piccart-Gebhart
- Journal of clinical oncology : official journal…
- 1 September 2007
PURPOSE The purpose of this analysis was to investigate trastuzumab-associated cardiac adverse effects in breast cancer patients after completion of (neo)adjuvant chemotherapy with or without… Expand
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†
- P. Ponikowski, D. V. van Veldhuisen, +12 authors S. Anker
- European heart journal
- 31 August 2014
Aim The aim of this study was to evaluate the benefits and safety of long-term i.v. iron therapy in iron-deficient patients with heart failure (HF). Methods and results CONFIRM-HF was a multi-centre,… Expand